Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to UY27510ApriorityCriticalpatent/UY27510A1/en
Publication of UY27510A1publicationCriticalpatent/UY27510A1/en
Refiere combinaciones farmacéuticas de atorvastatina o sal farmacéuticamente aceptable de la misma y agentes antihipertensorers, estuches de ensayo que contienen dichas combinaciones y procedimiento para itilizar dichas combinaciones para tratar sujetos que sufren de angina pectoris, ateroesclorosis, hipertensión e hiperlipidemia combinadas y para tratar sujetos que presenten síntomas de riesgo cardíaco, incluyendo seres humanos. Refiere también combinaciones aditivas y sinérgicas de atorvastatina o sal farmacéuticamente aceptable de la misma y agentes antihipertensores por los que estas combinaciones sinérgicas son útiles en el tratamiento de sujetos como los antes sugeridos.It refers to pharmaceutical combinations of atorvastatin or pharmaceutically acceptable salt thereof and antihypertensorers agents, test kits containing said combinations and procedure to similarize said combinations to treat subjects suffering from angina pectoris, atherosclorosis, hypertension and hyperlipidemia combined and to treat subjects presenting Heart risk symptoms, including humans. It also refers to additive and synergistic combinations of atorvastatin or pharmaceutically acceptable salt thereof and antihypertensive agents for which these synergistic combinations are useful in the treatment of subjects such as those suggested above.